154 related articles for article (PubMed ID: 17942887)
1. Targeting cancer with bugs and liposomes: ready, aim, fire.
Cheong I; Huang X; Thornton K; Diaz LA; Zhou S
Cancer Res; 2007 Oct; 67(20):9605-8. PubMed ID: 17942887
[TBL] [Abstract][Full Text] [Related]
2. Liposomal cancer therapy: exploiting tumor characteristics.
Kaasgaard T; Andresen TL
Expert Opin Drug Deliv; 2010 Feb; 7(2):225-43. PubMed ID: 20095944
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol.
Patel NR; Hatziantoniou S; Georgopoulos A; Demetzos C; Torchilin VP; Weissig V; D'Souza GG
J Liposome Res; 2010 Sep; 20(3):244-9. PubMed ID: 19883213
[TBL] [Abstract][Full Text] [Related]
4. Immunoliposomes for cancer therapy.
Kontermann RE
Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
[TBL] [Abstract][Full Text] [Related]
5. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
7. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
8. Liposomal delivery of photosensitising agents.
Chen B; Pogue BW; Hasan T
Expert Opin Drug Deliv; 2005 May; 2(3):477-87. PubMed ID: 16296769
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific liposomal drug release mediated by liposomase.
Cheong I; Zhou S
Methods Enzymol; 2009; 465():251-65. PubMed ID: 19913171
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
12. Bugging tumors to put drugs on target.
Juliano R
N Engl J Med; 2007 Mar; 356(9):954-5. PubMed ID: 17329705
[No Abstract] [Full Text] [Related]
13. Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model.
Hamzah J; Altin JG; Herringson T; Parish CR; Hämmerling GJ; O'Donoghue H; Ganss R
J Immunol; 2009 Jul; 183(2):1091-8. PubMed ID: 19561111
[TBL] [Abstract][Full Text] [Related]
14. Strategies for targeting tumors and tumor vasculature for cancer therapy.
Sreeramoju P; Libutti SK
Adv Genet; 2010; 69():135-52. PubMed ID: 20807606
[TBL] [Abstract][Full Text] [Related]
15. Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells.
Schiffelers RM; Storm G
Int J Pharm; 2008 Dec; 364(2):258-64. PubMed ID: 18773947
[TBL] [Abstract][Full Text] [Related]
16. Adapter protein for site-specific conjugation of payloads for targeted drug delivery.
Backer MV; Gaynutdinov TI; Patel V; Jehning BT; Myshkin E; Backer JM
Bioconjug Chem; 2004; 15(5):1021-9. PubMed ID: 15366955
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for drug delivery in cancer treatment.
Haley B; Frenkel E
Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
[TBL] [Abstract][Full Text] [Related]
18. A bacterial protein enhances the release and efficacy of liposomal cancer drugs.
Cheong I; Huang X; Bettegowda C; Diaz LA; Kinzler KW; Zhou S; Vogelstein B
Science; 2006 Nov; 314(5803):1308-11. PubMed ID: 17124324
[TBL] [Abstract][Full Text] [Related]
19. Physical mechanisms and methods employed in drug delivery to tumors.
Besić E
Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
[TBL] [Abstract][Full Text] [Related]
20. Liposomes composed of reconstituted membranes for induction of tumor-specific immunity.
Westerman LE; Jensen PE
Methods Enzymol; 2003; 373():118-27. PubMed ID: 14714400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
